antidepressants

According to a scientific study published Wednesday in Nature, a group of computational biologists might have found therapeutic potential in a handful of LSD-adjacent molecules. They generated 3D iterations of more than 75 million related molecules that don’t actually exist but could,...

Seelos Therapeutics Inc (NASDAQ: SEEL) has announced data from Part 1, the open-label cohort, of its Proof-of-Concept study of SLS-002 for acute suicidal ideation and behavior in patients with Major Depressive Disorder. On depression scale, 76.5% response rate on Day 1 (n=17),...

Alkermes Plc (NASDAQ: ALKS) shares were trading down Friday as the Street weighed reports of regulatory setbacks for the biopharma.  What Happened The Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee...

SAGE Therapeutics Inc (NASDAQ: SAGE) has had a laudable 109-percent run in recent months after meeting primary endpoints in multiple trials and securing regulatory approvals.  It found further reason to celebrate Monday with the conversion of a new Street advocate. The Rating Morgan Stanley...